(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

OXABICICLO-HEPTANOS PARA O TRATAMENTO DE CÂNCER DE PULMÃO DE PEQUENAS CÉLULAS

ArquivadaInvention PatentPCT · US2021051647

Application data

Number

112023013946

Type

Invention Patent

Filing

09/23/2021

Publication

08/15/2023

PCT

US2021051647

Progress at the INPI

  1. Filing09/23/21
  2. Publication08/15/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 09/23/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 12/17/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

LIXTE BIOTECHNOLOGY, INC.

US

Inventors

J. K. (pessoa física)

US

R. S. (pessoa física)

US

Technical data

Priority claims

US

63/139,047 · 01/19/2021

Abstract

OXABICICLO-HEPTANOS PARA O TRATAMENTO DE CÂNCER DE PULMÃO DE PEQUENAS CÉLULAS. A presente invenção fornece um método para o tratamento de um indivíduo que sofre de CPPC compreendendo a administração ao indivíduo de uma quantidade eficaz de um inibidor de PP2A e opcionalmente um ou mais agentes anticancerígenos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

12/17/2024

RPI 2815

Arquivamento - Art. 33 da LPI

#11.1

10/01/2024

RPI 2804

Notificação de entrada na fase nacional - PCT

#1.3

08/15/2023

RPI 2745

Alteração de dados cadastrais

#1.1

07/25/2023

RPI 2742

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.